Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nor-Am Chemical Company was a prominent life sciences organization specializing in the development and commercialization of agricultural chemicals, including herbicides, insecticides, and fungicides. Originally established as a joint venture between the German pharmaceutical giant Schering AG and the American company Morton Norwich Products, it became a key player in the North American crop protection market. The company was headquartered in Wilmington, Delaware, and operated significant manufacturing facilities in Arkansas and Michigan. Nor-Am is best known for its portfolio of sugar beet herbicides, such as Betamix and Betanex, which were industry standards for decades. In 1994, the company was merged with the agrochemical interests of Hoechst AG to form AgrEvo, a move that consolidated Schering's agricultural business. Through subsequent industry mergers, Nor-Am's legacy and product lines were eventually integrated into Bayer CropScience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nor-Am Company.